Independence Blue Cross recently sold a minority equity stake in its subsidiary Tandigm Health to Penn Medicine, which will have representation on the Tandigm Board of Directors, effective Jan. 1.
Founded in 2014, Tandigm serves the five-county Philadelphia region and supports a network of 400 primary care doctors, many of which are affiliated with regional community hospitals.
The deal allows more patients to find primary care providers close to home, and the existing Tandigm physician network will have access to Penn Medicine services and resources.
“We are excited to move to the next generation of value-based care, expanding member access to the benefits of population health management and ensuring that they can access quality care where and when they need it,” Gregory E. Deavens, Independence Blue Cross president and CEO, said. “This means connecting every aspect of the healthcare system, from the primary care physician to the hospital and all the other critical care settings, including the home.”
Penn Medicine will work with Tandigm for all primary care value-based programs.
Independence and Penn Medicine have collaborated in the past. They launched a program in 2017 that dramatically reduced the number of avoidable readmissions to Penn Medicine hospitals after treatment and discharge.